Seventh stakeholders' forum on the implementation of the new pharmacovigilance legislation
Date:
27/09/2013
Location:
European Medicines Agency, London, UK
This stakeholders' forum is intended to provide an update on key changes and aspects implemented since the sixth stakeholders' forum and to share positive and negative experiences on the implementation of the pharmacovigilance legislation across all stakeholders. Registration closed.
-
List item
Agenda - Seventh stakeholders' forum on the implementation of the new pharmacovigilance legislation (PDF/67.56 KB)
First published: 07/10/2013
Last updated: 07/10/2013
EMA/422496/2013 -
List item
Presentation - Pharmacovigilance – risk-benefit monitoring cycle. A global undertaking (Fergus Sweeney) (PDF/162.17 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - PRAC’s perspective on implementation: strengthening public-health protection (June Raine) (PDF/2.11 MB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Implementing the pharmacovigilance legislation: focus on European Union level activities (Peter Arlett) (PDF/2.27 MB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Croatia’s perspective on implementation of the new pharmacovigilance legislation (Marina Dimov Di Giusti) (PDF/2.75 MB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - The new pharmacovigilance legislation. A national agency’s views (Sabine Straus) (PDF/2.16 MB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - July 2012 – September 2013: do patients see an impact of the new pharmacovigilance measures? (Franà§ois Houà¿ez) (PDF/3.97 MB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - European Patients Forum member survey on pharmacovigilance. First results and tentative conclusions (Kaisa Immonen-Charalambous) (PDF/681.36 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Pharmacovigilance legislation present situation and perspectives for Polish patients (Rafal Swierzewski) (PDF/524.57 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Making medicines affordable (Ana Maria Tomà©) (PDF/759.31 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Industry perspective: Non-prescription medicines (Hubertus Cranz) (PDF/165.33 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - New European Union pharmacovigilance legislation. Innovative industry’s perspective on implementation. First year experience (Laurent Auclert) (PDF/133.82 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Geriatrician’s perspective on implementation of the new pharmacovigilance legislation (Jean-Pierre Baeyens) (PDF/243.05 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Implementation of the pharmacovigilance legislation. The views of physicians (Erzsà©bet Podmaniczky) (PDF/154.64 KB)
First published: 07/10/2013
Last updated: 07/10/2013 -
List item
Presentation - Implementation of the pharmacovigilance directive (John Chave) (PDF/769.12 KB)
First published: 07/10/2013
Last updated: 07/10/2013
Welcome and introduction
Implementing the pharmacovigilance legislation: what has been achieved?
PRAC's perspective on implementation
Member States' perspective on implementation
Member States' perspective on implementation
Patients' perspective on implementation
Patients' perspective on implementation
Patients' perspective on implementation
Industry's perspective on implementation
Industry's perspective on implementation
Industry's perspective on implementation
Healthcare professionals' perspective on implementation
Healthcare professionals' perspective on implementation
Healthcare professionals' perspective on implementation